Investment
Features
FeesSafety
Academy
More
Pluang+

Knife River Corp rated Hold due to low returns and overvalued stock despite 13% revenue growth in Q2

Analyst Insights
06 Aug 2026
Seeking Alpha
View Source
Bearish
pluang ai news

Knife River Corporation reported a strong 13% revenue growth in Q2 but faced margin pressure from rising costs and fuel prices, partially offset by price increases. Despite benefits from local monopolies in its aggregates segment, the company shows low returns on invested capital and limited potential for multiple expansion. At a 26x price-to-earnings ratio, the stock appears overvalued with no clear catalysts for significant upside or margin improvement, leading to a Hold rating. Investors should be cautious given the structural challenges and valuation concerns.

More News

Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Seaport Global raised the price target for Madison Square Garden Sports Corp. to $473, reflecting a 17.13% potential upside. The company reported strong fiscal Q4 results with earnings per share of $1.19, beating estimates of $0.72, and revenue risin...

Company Fundamentals
Bullish
56 minutes ago
Airbus leads aerospace market with strong orders despite production challenges

Airbus leads aerospace market with strong orders despite production challenges

Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...

Market News
Bullish
1 hour ago
PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reported a Q2 2026 GAAP loss per share of $0.87 and a non-GAAP loss of $0.27, beating analyst expectations of a $0.47 loss. Revenue was $33,000, below the $49,000 consensus. Lucid Diagnostics, an investment of PAVmed, generated $1.5 million in...

Company Fundamentals
Bearish
1 hour ago
Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target is expected to report second-quarter earnings of $2.25 per share, a 9.8% increase from last year, with revenues projected at $26.06 billion, up 3.4%. Despite these positive forecasts, the stock has surged 57% year-to-date, leading an analyst t...

Company Fundamentals
Neutral
1 hour ago
RLX Technology misses Q2 earnings estimates but sees 14.8% revenue growth driven by international sales.

RLX Technology misses Q2 earnings estimates but sees 14.8% revenue growth driven by international sales.

RLX Technology reported Q2 2026 earnings per share of $0.03 and revenue of $148.87 million, missing analyst expectations. Despite this, the company achieved 14.8% year-over-year revenue growth, mainly due to its expanding international market, which ...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App